Relative infectiousness of SARS-CoV-2 vaccine breakthrough infections, reinfections, and primary infections Read more about Relative infectiousness of SARS-CoV-2 vaccine breakthrough infections, reinfections, and primary infections Nature Communications
Effectiveness of mRNA-1273 and BNT162b2 Vaccines in Qatar Read more about Effectiveness of mRNA-1273 and BNT162b2 Vaccines in Qatar NEJM
Waning mRNA-1273 Vaccine Effectiveness against SARS-CoV-2 Infection in Qatar Read more about Waning mRNA-1273 Vaccine Effectiveness against SARS-CoV-2 Infection in Qatar NEJM
Protection against the Omicron Variant from Previous SARS-CoV-2 Infection Read more about Protection against the Omicron Variant from Previous SARS-CoV-2 Infection NEJM
Effect of mRNA Vaccine Boosters against SARS-CoV-2 Omicron Infection in Qatar Read more about Effect of mRNA Vaccine Boosters against SARS-CoV-2 Omicron Infection in Qatar NEJM
Effects of BA.1/BA.2 subvariant, vaccination and prior infection on infectiousness of SARS-CoV-2 omicron infections Read more about Effects of BA.1/BA.2 subvariant, vaccination and prior infection on infectiousness of SARS-CoV-2 omicron infections Journal of Travel Medicine
Duration of mRNA vaccine protection against SARS-CoV-2 Omicron BA.1 and BA.2 subvariants in Qatar Read more about Duration of mRNA vaccine protection against SARS-CoV-2 Omicron BA.1 and BA.2 subvariants in Qatar Nature Communications
Severity, Criticality, and Fatality of the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Beta Variant Read more about Severity, Criticality, and Fatality of the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Beta Variant Clinical Infectious Diseases
Effects of Previous Infection and Vaccination on Symptomatic Omicron Infections Read more about Effects of Previous Infection and Vaccination on Symptomatic Omicron Infections NEJM
Protection of Omicron sub-lineage infection against reinfection with another Omicron sub-lineage Read more about Protection of Omicron sub-lineage infection against reinfection with another Omicron sub-lineage Nature Communications
